The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Assessment of Anti-Angiogenic Drug in Cancer Therapy
Abstract
It has been documented in the literature that a solid tumor survives by the generation of micro-vessels around it. This phenomenon is known as angiogenesis. Angiogenesis is governed by two factors, namely Tumor Angiogenic Factor (TAF) secreted by the tumor cells and tissue Fibronectin (FNT) concentration in the extra-cellular space. These two factors help in mobilization of endothelial cells from nearby blood vessels. At the initial phase of angiogenesis, neighboring blood vessels affect in formation of capillary sprouts. In this work, to the authors develop a clinically relevant analytical model that could act as an effective tracing system of tumor growth. The author has performed a quantitative assessment of tumor angiogenesis. This analytical method is a correlation between tumor system and vasculature system through an analytical assessment at peripheral blood circulatory of tumor milieu.
Related Content
|
.
© 2024.
27 pages.
|
|
.
© 2024.
10 pages.
|
|
.
© 2024.
13 pages.
|
|
.
© 2024.
6 pages.
|
|
.
© 2024.
23 pages.
|
|
.
© 2024.
14 pages.
|
|
.
© 2024.
7 pages.
|
|
|